Blog

Industry Voices

A Conversation with Brad Hightower

Inato co-founders sat down for a transparent conversation with Brad Hightower to explore Inato’s mission, better understand how the platform works to...

Event Recap

A Closer Look at SCOPE 2023

At SCOPE 2023, four members of Inato's team presented on the advantages community-based sites bring to clinical research.

Industry Voices

A Month of Gratitude

This month, in the spirit of giving thanks, our team at Inato reached out to collaborators across our network to hear what they're grateful for.

Event Recap

Investing in a Community-Based Future

Inato Co-Founder and CEO, Kourosh Davarpanah, sat down with fellow industry leaders to address community-based solutions to the barriers disrupting...

Industry Voices

Interview with Robert M. Wachter of UCSF

Robert M. Wachter, MD is Professor and Chair of the Department of Medicine at the University of California, San Francisco, where he is the Holly...

Industry Voices

Interview with Christophe Massard, MD PhD

Christophe Massard, MD PhD is a medical oncologist and the department head at Drug Development Department (DITEP) in Paris, France. He is a member of...

Event Recap

A Closer Look At DPHARM 2022

To a crowded room of pharma leaders, Inato’s Liz Beatty and Otsuka’s Candace Saldarini presented their teams’ findings on how collaborating with...

Event Recap

A Closer Look at SCOPE 2022

Inato’s Liz Beatty spoke alongside Sanofi’s Kim Hawkins to present how their teams worked together to accelerate and diversify trials.

Industry Topics

The Pharma Trends that Defined 2021

The continuation of the pandemic in 2021 lead to defining new trends in pharma, pushing clinical trials towards inclusivity, innovation, and...

Site Insights

Site Insights: RSV Vaccine

Last month, Inato spoke with 13 research sites around the world to gather information on their capabilities to perform in an RSV vaccine trial.